Preferred Label : olodaterol;

MeSH note : a beta1-adrenoceptor agonist; structure in first source;

CISMeF synonym : BI 1744 CL;

MeSH synonym : 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one;

MeSH hyponym : BI-1744 CL;

CISMeF hyponym : Olodaterol Hydrochloride;

Is substance : O;

UNII : VD2YSN1AFD;

InChIKey : COUYJEVMBVSIHV-SFHVURJKSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2967175/fr/striverdi-respimat
2019
false
false
false
France
evaluation of the transparency committee
Striverdi Respimat
olodaterol
benzoxazines

---
https://www.has-sante.fr/portail/jcms/c_2969204/fr/spiolto-respimat
2019
false
false
false
France
Tiotropium Bromide
olodaterol
tiotropium-olodaterol
drug combinations
administration, inhalation
olodaterol and tiotropium bromide
evaluation of the transparency committee
Spiolto Respimat
benzoxazines
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676778/fr/spiolto-respimat
2016
false
false
false
France
French
evaluation of the transparency committee
administration, inhalation
insurance, health, reimbursement
treatment outcome
drug combinations
olodaterol and tiotropium bromide
pulmonary disease, chronic obstructive
bronchodilator agents
cholinergic antagonists
adult
adrenergic beta-1 receptor agonists
olodaterol
Tiotropium Bromide
benzoxazines

---
http://www.has-sante.fr/portail/jcms/c_2027374/fr/striverdi-respimat-olodaterol-bronchodilatateur
http://www.has-sante.fr/portail/jcms/c_2027374/fr/striverdi-respimat
2015
false
France
French
olodaterol
guidelines for drug use
evaluation of the transparency committee
insurance, health, reimbursement
adult
aged
forced expiratory volume
olodaterol
olodaterol
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug approval
bronchodilator agents
bronchodilator agents
pulmonary disease, chronic obstructive
treatment outcome
benzoxazines
benzoxazines
benzoxazines

---
Summary Basis of Decision (SBD) for Striverdi Respimat
Olodaterol Hydrochloride, 2.5 µg, olodaterol/actuation, solution for inhalation
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00192
2013
false
Canada
French
English
olodaterol
drug information
olodaterol
olodaterol
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug approval
canada
bronchodilator agents
bronchodilator agents
pulmonary disease, chronic obstructive
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
benzoxazines
benzoxazines

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.